Integrating CERVICO-Vaginal Smear into the Overall Management of Women Living with Human Immunodeficiency Virus (HIV) at the Day Hospital of the Infectious Diseases Department at the University Hospital Mohammed VI in Marrakesh


Cervical cancer is the fourth leading cause of cancer and cancer death among women worldwide [1]. According to the International Agency for Research on Cancer (IARC) in 2018, the global incidence is estimated at 570,000 new cases per year, of which more than 80% occur in developing countries [1]. In Morocco, the cervical cancer represents a major public health problem. It ranks second, after breast cancer in Moroccan women [2]. The incidence of cervical cancer remains high among women living with HIV. However, many studies have shown that this population has an increased risk of developing intraepithelial cervical neoplasia [3]. In the fight against cervical cancer, Morocco has a national cancer control programme under the aegis of the LALLA SALMA Foundation since 2006, thus enabling the creation of reference centers for screening and diagnosis of cervical cancer [4]. Women living with HIV often escape this program because of fear of stigmatization and disclosure of their HIV status. It is in this perspective that we have integrated the implementation of the cervico-vaginal smear (Pap smear) into the activity of the infectious diseases department for early detection in order to make recommendations regarding management.

Read More About This Article: https://crimsonpublishers.com/igrwh/pdf/IGRWH.000578.pdf

Read More About Crimson Publishers: https://crimsonpublishers.com/igrwh/

Comments

Popular posts from this blog

Brazilian Butt Lifts: An Editorial_ Crimson Publishers

Psychological Health Status and Oral Health Outcomes of Pregnant Women: Practical Implications_ Crimson Publishers